RecruitingNot applicableNCT06341452

Comparison of Individualized Sodium Management Versus Standard Treatment in Hemodialysis

Studying Complication in hemodialysis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Fresenius Medical Care Deutschland GmbH
Principal Investigator
Martin Jirovec, Dr.
Fresenius Medical Care - DS, s.r.o., Marianske Lazne; Czech Republic
Intervention
Hemodialysis or Hemodiafiltration either with sodium zero-diffusive treatment or standard treatment without sodium-control(device)
Enrollment
130 target
Eligibility
18 years · All sexes
Timeline
2025 – 2026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06341452 on ClinicalTrials.gov

Other trials for Complication in hemodialysis

Additional recruiting or active studies for the same condition.

See all trials for Complication in hemodialysis →

← Back to all trials